
Curewell Pharmakon Private Limited
About Curewell Pharmakon Private Limited
Data last updated:
Curewell Pharmakon Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 31 March 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24231JK1989PTC001099. Its GSTIN is 01AAACC6571D1Z8 (Jammu and Kashmir).
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Anu Gupta and Sumati Mahajan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 145 Raghunath Pura, Jammu, Jammu and Kashmir, India – 180001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.76 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.27 Lakh (net margin 0.5%) and EBITDA of ₹4.66 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 17% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹54.21 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Curewell Pharmakon Private Limited's registered office is in Jammu, Jammu And Kashmir. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No. 145 Raghunath Pura, Jammu, Jammu and Kashmir, India – 180001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Curewell Pharmakon Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curewell Pharmakon is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curewell Pharmakon Private Limited, buy the company report.
Financials of Curewell Pharmakon Private Limited
FY 2025 filings availableCurewell Pharmakon Private Limited reported revenue of ₹2.76 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curewell Pharmakon Private Limited, buy the company report.
Board of directors of Curewell Pharmakon Private Limited
Curewell Pharmakon has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anu Gupta | Director | 17 Nov 2017 | 8 Years 11 Months | Current |
| Sumati Mahajan | Director | 31 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Curewell Pharmakon Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dalma Infracon Private Limited | ₹2.76 Cr (FY 2025) | 39.0% | Jamshedpur, Jharkhand, India | |||
| Webtreasure Eservices Private Limited | ₹2.76 Cr (FY 2024) | Gurgaon, Haryana, India | ||||
| Mark Enclave Private Limited | ₹2.76 Cr (FY 2025) | -71.0% | Kolkata, West Bengal, India | |||
| Kvson Endeavour Private Limited | ₹2.76 Cr (FY 2025) | 9.0% | Siliguri, West Bengal, India | |||
| Damar India Private Limited | ₹2.76 Cr (FY 2025) | -9.0% | Begusarai, Bihar, India | |||
| Curewell Pharmakon Private Limitedthis company | ₹2.76 Cr (FY 2025) | ₹1.27 Lakh | 0.5% | -2.0% | 2 | Jammu, Jammu And Kashmir, India |
| M. K. Aruna Leasing & Properties Limited | ₹2.76 Cr (FY 2025) | 96.0% | Delhi, India | |||
| Soltex Trade Private Limited | ₹2.76 Cr (FY 2025) | 56.0% | Delhi, India | |||
| Zoonis India Private Limited | ₹2.76 Cr (FY 2025) | -2.0% | Rani Khera, Delhi, India | |||
| Genisys Global IT Solutions Private Limited | ₹2.76 Cr (FY 2025) | -8.0% | New Delhi, Delhi, India | |||
| Welfeed Remedies Private Limited | ₹2.76 Cr (FY 2025) | 2.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Curewell Pharmakon Private Limited, buy the company report.
Auditor
Curewell Pharmakon Private Limited is audited by WIG SINBAD & CO CHARTERED ACCOUNTANTS for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| WIG SINBAD & CO CHARTERED ACCOUNTANTS | FY 2017 | 010893N |
Shareholding
The shareholding of Curewell Pharmakon Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Curewell Pharmakon Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jun 2023 | 100764049 | Hdfc Bank Limited | ₹5.21 Lakh | Open | |
| 29 May 2023 | 100747277 | The Jammu and Kashmir Bank Limited | ₹21 Lakh | Open | |
| 24 Dec 2002 | 90323860 | Central Bank of India | ₹22 Lakh | Open | |
| 28 Jan 1993 | 90323644 | Central Bank of India | ₹2 Lakh | Open | |
| 21 Jul 1992 | 90324022 | Central Bank of India | ₹4 Lakh | Open |
To see the full charge records of Curewell Pharmakon Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Curewell Pharmakon Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curewell Pharmakon Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Curewell Pharmakon Private Limited has a workforce of 2 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Curewell Pharmakon has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AAACC6571D1Z8 | Jammu and Kashmir | Active | 08 Jul 2017 |
To see the full GST registrations and return filing status of Curewell Pharmakon Private Limited, buy the company report.
Recent activity
Curewell Pharmakon Private Limited has 9 board changes on record since 2017: 2 appointments and 7 cessations. The latest: Sumati Mahajan ceased to be Additional Director on 30 Nov 2021.
8 earlier events are in the company report.
Frequently asked questions
Curewell Pharmakon is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in other wholesale, within the trading industry. It was incorporated on 31 March 1989 (37+ years old) and is registered under CIN U24231JK1989PTC001099.
Curewell Pharmakon has 2 current directors:
- Anu Gupta - Director
- Sumati Mahajan - Director
The latest financial statements of Curewell Pharmakon on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Curewell Pharmakon is 01AAACC6571D1Z8, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Curewell Pharmakon is U24231JK1989PTC001099. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curewell Pharmakon was incorporated on 31 March 1989, making it 37+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of Curewell Pharmakon by revenue are Dalma Infracon Private Limited, Webtreasure Eservices Private Limited, Mark Enclave Private Limited, Kvson Endeavour Private Limited, Damar India Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Sumati Mahajan ceased to be Additional Director on 30 Nov 2021. Narinder Sharma ceased to be Director on 31 Dec 2020. Sumati Mahajan was appointed as Director on 31 Dec 2020. Curewell Pharmakon has 9 board changes on record in total.
The registered office of Curewell Pharmakon is at H.No. 145 Raghunath Pura, Jammu, Jammu and Kashmir, India – 180001.
Curewell Pharmakon operates in the trading industry, in the other wholesale segment.
Curewell Pharmakon has open charges of ₹54.21 Lakh and no satisfied charges on record as per latest MCA filings.

